Satiety

About Satiety

Satiety, Inc. operated as a medical device company focused on the development and commercialization of minimally invasive solutions for obesity. Founded in 2000 and based in Palo Alto, California, the firm targeted the significant market of individuals seeking less invasive alternatives to traditional bariatric surgery.

The company's core product was the Transoral Gastroplasty (TOGA) system. This device was engineered to perform an incision-less procedure through the mouth, using flexible staplers to create a restrictive narrow sleeve within the patient's stomach. The primary benefit of this approach was to reduce the stomach's capacity, which in turn slowed the passage of food and induced a feeling of fullness, or satiety, after smaller meals, thereby aiding in weight loss. The procedure was designed to eliminate the external incisions and implant-related risks associated with conventional obesity surgeries.

From a financial perspective, Satiety was a venture-capital-backed entity. The company successfully raised approximately $63.5 million over five funding rounds, starting with its first round in June 2005 and culminating in a Series D round on September 25, 2009, which brought in $25.3 million. Its investor syndicate included prominent venture capital firms such as Venrock, Morgenthaler, Three Arch Partners, and HLM Venture Partners, indicating strong market confidence in its technological approach during its operational years.

The company is now classified as deadpooled and inactive, having been acquired or merged around January 2011.